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Abstract: A 68 year-old Japanese man, who had been suffering from immobilization and disuse syndrome, was admitted to our hospital 
for evaluation of polyuria with polyposia, hyponatremia and low blood pressure. His plasma osmolality was greater than that of his 
urine. His endocrinological examination revealed low levels of plasma adrenocorticotropic hormone (ACTH) and cortisol, and a nor-
mal response of ACTH to the corticotrophin-releasing hormone (CRH) challenge. Plasma ACTH did not increase with insulin loading. 
A low plasma vasopressin (AVP) level and no response of AVP to a 5% saline administration were observed. We diagnosed central adre-
nal insufficiency with central diabetes insipidus. Six months after starting administration of hydrocortisone and 1-deamino-8D-arginine 
vasopressin, his psychological symptoms had improved, and 1.5 years after starting treatment, he was able to walk. In conclusion, it 
is not particularly rare for adrenal insufficiency to be misdiagnosed as depression. However, a correct early diagnosis is necessary, 
because, if adrenal insufficiency is not definitively diagnosed, the patient’s quality of life diminishes markedly.
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Adrenal  insufficiency  is  a  relatively  rare  disease. 
Primary  adrenal  insufficiency  has  a  prevalence  of 
90–140  per  million,  and  the  estimated  prevalence 
of  secondary  and  tertiary  (central)  adrenal 
insufficiency is 150–280 per million.1 Any process 
that involves the hypothalamus and interferes with 
corticotrophin-releasing  hormone  (CRH)  secretion, 
such as hypothalamic tumors, surgery and irradiation, 
and autoimmune hypothalamic disease, will result in 
tertiary adrenal failure.2 Weakness, fatigue, myalgia 
and  psychiatric  symptoms  are  known  to  be  both 
common and non-specific in patients with central adre-
nal insufficiency. Thus, central adrenal insufficiency 
is often misdiagnosed as depression and/or chronic 
anxiety disorder.3 We present herein a patient with 
central adrenal insufficiency and diabetes insipidus 
who was misdiagnosed as having severe depression.
Case Presentation
A 68 year-old Japanese man, who had been suffering 
from immobilization and disuse syndrome, was admit-
ted to our hospital for evaluation of polyuria with 
polyposia, hyponatremia and low blood pressure. He 
had been diagnosed with depression at another hos-
pital, based on loss of interest in almost all activi-
ties, decreased appetite and social withdrawal, and 
had been treated with anti-depressants and antipsy-
chotics, such as clomipramine, tiapride, milnacipran, 
zolpidem, risperidone and levomepromazine (metho-
trimeprazine), for the previous two years. However, 
his general condition had not improved. Another psy-
chiatrist recognized an increase in urinary volume, 
low blood pressure and hyponatremia.
On  physical  examination,  a  depressive  effect, 
hypotension and arthrogryposis were observed. His 
urinary  volume  was  approximately  3000  mL/day. 
Hematological  data  showed  mild  anemia  and  bio-
chemical analysis detected hyponatremia (133 mM) 
on admission. Serum levels of aspartate aminotrans-
ferase, urea nitrogen, creatinine and C-reactive peptide 
were  elevated  (40  IU/L,  38.7  mg/dL,  1.52  mg/dL 
and 0.8 mg/dL, respectively). His plasma osmolality 
(pOsm)  was  greater  than  that  of  his  urine  (uOsm) 
(355  mOsm/kg  and  288  mOsm/kg,  respectively). 
Endocrinological examinations showed plasma adre-
nocorticotropic hormone (ACTH) and cortisol levels 
of 23.5 pg/mL (normal range: 7.4–55.7 pg/mL) and 
3.6 µg/dL (normal range: 4.0–18.3 µg/dL), respectively, 
at 7:30 a.m. with loss of circadian rhythm. Mean 24 hour 
urinary  17-hydroxycorticosteroid  and  17-ketosterol 
levels  were  below  normal  at  1.5  mg/day  (normal 
range:  4–12  mg/day)  and  2.2  mg/day  (normal 
range: 5–20 mg/day), respectively. The responses of 
plasma ACTH and cortisol to intravenous injection 
of  CRH  were  normal.  Plasma ACTH  and  cortisol 
levels  did  not  increase  in  response  to  intravenous 
injection of insulin. The cortisol response to a single 
administration of  1–24 ACTH was normal. Levels of 
free triiodothyronine and free thyroxin were normal, 
and  thyroid-stimulating  hormone  (TSH)  showed  a 
normal  response  to  thyrotropin-releasing  hormone 
injection.  Levels  of  plasma  prolactin,  growth  hor-
mone and insulin like growth factor-1 were 9.8 ng/mL 
(normal range: 3.58–12.78 ng/mL), 0.1 ng/mL (normal 
range: ,0.17 ng/mL) and 159 ng/mL (normal range: 
42–250 ng/mL), respectively. The plasma vasopressin 
(AVP) level was relatively low, at 0.4 pg/mL (normal 
range:  0.3–3.5  ng/mL).  AVP  showed  no  response 
to a 5% saline loading test. T1-weighted magnetic 
resonance imaging of the pituitary gland showed an 
empty sella and disappearance of high intensity at the 
posterior lobe (Fig. 1).
We  diagnosed  central  (tertiary)  adrenal  insuffi-
ciency with central diabetes insipidus. Replacement 
therapy, with 15 mg of hydrocortisone and 10 µg/day 
of 1-deamino-8D-arginine vasopressin, was started, 
and of the patient’s antidepressants and antipsychotics 
were canceled at the same time. A few weeks after start-
ing the hydrocortisone treatment, his psychological 
symptoms, including loss of interest in most activities 
and  decreased  appetite,  had  improved.  Six  months 
after starting the treatment, his mobility also improved 
and he was able to walk.
Discussion
Our  patient  initially  presented  with  psychiatric 
manifestations for which he had been treated with 
antidepressants without improvement. As a result, he 
suffered from immobilization and disuse syndrome 
for two years. However, his physical findings and data 
showed increased urinary volume, low blood pressure 
and hyponatremia, and the endocrinological findings 
supported a diagnosis of tertiary adrenal insufficiency 
with central diabetes insipidus. It is well known that 
depression manifests with apathy, poverty of thought 
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long-standing adrenal insufficiency. Twenty percent 
of patients with adrenal insufficiency are diagnosed 
more than five years after the onset of symptoms. More 
than 67% of patients consult at least three physicians, 
and 68% are initially given an incorrect diagnosis, 
usually of psychiatric disorders and gastrointestinal 
disease.4 Most psychiatric symptoms disappear within 
a few days after adequate glucocorticoid therapy is 
begun; however, psychosis reportedly may persist for 
several months.5 In our case, a few weeks after start-
ing  administration  of  hydrocortisone,  the  patient’s 
psychological symptoms showed improvement, and 
six months after starting the treatment, he was able 
to walk. Therefore, we suggest the necessity of blood 
testing for ACTH and cortisol in the field of psychiatry 
to ensure an early diagnosis of adrenal insufficiency.
Any process that involves the hypothalamus and 
interferes with CRH secretion, such as hypothalamic 
tumors,  surgery  and  irradiation,  and  autoimmune 
hypothalamic disease, will result in tertiary adrenal 
failure.2  In  this  case,  although  low  ACTH  and 
cortisol levels and a normal ACTH response to CRH 
administration were observed, there was no response 
of ACTH to an insulin challenge. In addition, AVP 
was low while pOsm was high, and there was no AVP 
response to a 5% saline loading. Therefore, the patient 
was diagnosed with tertiary adrenal insufficiency with 
central diabetes insipidus. It has been reported that 
30% of central diabetes insipidus cases are idiopathic, 
and that lymphocytic hypophysitis and autoimmune 
hypothalamic  disease  may  cause  central  diabetes 
insipidus.6–8 The paraventricular nucleus (PVN) in the 
hypothalamus is the site of most CRH production,9 
and AVP is also synthesized in both the supraoptic 
nucleus and the PVN in the hypothalamus.10,11 In our 
patient’s  case,  tertiary  adrenal  failure  and  central 
diabetes insipidus may have developed due to dam-
age to the hypothalamus, including the PVN, though 
the cause of the damage is unclear and may thus be 
idiopathic.
In this case, the volume of urine was relatively 
low for diabetes insipidus, initially being 3000 ml. 
However,  the  urinary  volume  increased  markedly 
after  steroid  replacement  therapy.  Central  diabetes 
insipidus is known to be masked by the presence of 
glucocorticoid deficiency, so-called masked diabetes 
insipidus,10,12 Glucocorticoid deficiency causes AVP-
dependent as well as independent impairment of water 
diuresis due to renal factors. It was recently reported 
that  the  production  of  aquaporin  2,  a  vasopressin-
dependent water channel in the kidney, is enhanced 
in the absence of glucocorticoids.13 As a result, the 
antidiuretic  action  of  vasopressin  is  exaggerated, 
such that the masked diabetes insipidus in this patient 
surfaced once treatment had begun.
In  conclusion,  misdiagnosis  of  adrenal 
insufficiency  is  not  particularly  rare.  However,  a 
correct  early  diagnosis  is  necessary,  because,  if 
adrenal insufficiency is not definitively diagnosed, 
the  patient’s  quality  of  life  is  markedly  reduced. 
We have described this patient with tertiary adre-
nal failure associated with diabetes insipidus, mis-
diagnosed as severe depression, to raise clinicians’ 
awareness of this disorder.
Disclosure
This  manuscript  has  been  read  and  approved  by 
all  authors.  This  paper  is  unique  and  is  not  under 
consideration by any other publication and has not been 
published elsewhere. The authors and peer reviewers 
of this paper report no conflicts of interest. The authors 
confirm that they have permission to reproduce any 
copyrighted  material. Written  consent  was  obtained 
from the patient for publication of this study.
References
1.  Arlt W, Allolio B. Adrenal insufficiency. Lancet. 2003;361:1881–93.
2.  Endert E, Ouwehand A, Fliers E, Prummel MF, Wiersinga WM. Establishment 
of reference values for endocrine tests. Part IV: adrenal insufficiency. Neth J 
Med. 2005;63:435–43.
0
2
4
6
8
10
12
250 260 270 280 290 300 310 320
A
V
P
 
(
p
g
/
m
L
)
Plasma osmolality (mOsm/kg)
Figure 1. Response of AVp to 5% saline loading test. There was no 
response of AVp to a 5% saline loading test in our patient (closed cir-
cle). The gray area represents the normal response of AVp to 5% saline 
administration.
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Figure  2.  Coronal  T1-weighted  magnetic  resonance  imaging  of  the 
  pituitary gland. The arrow indicates an empty sella.
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